Acurion is a cancer diagnostics company focused on improving precision oncology through its OncoGaze technology. By delivering critical genomic insights at the biopsy stage, OncoGaze helps oncologists identify actionable biomarkers quickly to enable timely, personalized therapies. The company targets solid tumors such as ovarian, pancreatic, and breast cancers and emphasizes fast biomarker screening through digital histology analysis. Headquartered and operating in the oncology space, Acurion aims to expand access to targeted treatments for more patients.
No recent news for this company.